Contributed By Pakharenko & Partners (Kyiv)
According to the law, publication of information about any medicines, regardless of their inclusion in the list of medicines prohibited for advertising, unregistered medicinal products, or the products that are in the process of development or putting into production, shall be allowed in specialised publications intended for healthcare and pharmaceutical professionals, as well as in the materials distributed at specialised seminars dedicated to medical issues.
Such information may include only the name, characteristics, therapeutic properties and possible side effects of a medicine. The fact that such information is not qualified as advertising of medicinal products indicates that in this part the legislation of Ukraine approximates to the EU practice (in particular, Directive 2001/83).
The law does not specify an exact scope of information to be provided in each of these categories concerning the name, characteristics, therapeutic properties and possible side effects of a medicine, which allows providing a broader scope of information about the medicine. In the course of development of layouts of informational materials, the following approaches are recommended: